Dario Altieri

Dario Carlo Altieri, an Italian-born physician-scientist, is the president and CEO of The Wistar Institute in Philadelphia.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Dario Carlo Altieri, an Italian-born physician-scientist, is the president and CEO of The Wistar Institute in Philadelphia. He is also the holder of the Robert and Penny Fox Distinguished Professor and the director of the National Cancer Institute-designated Ellen and Ronald Caplan Cancer Center at The Wistar Institute.

Research

His research has focused on Inhibitors of Apoptosis (IAP), a family of genes essential for proliferation and survival of cells. His work has identified survivin, one of these IAP genes, is over-produced in almost every human cancer, and his team is currently studying the biology of survivin and how it could be used to develop treatments for cancer.

Altieri has also been involved in the development of gamitrinib, a Hsp90 inhibitor that was shown to disable the activity of mitochondria in cancerous cells. In 2013, Altieri and his team received a $1.5 million grant from the United States Department of Defense to prepare the drug for human trials.

He also co-founded the Cancer Biology Training Consortium and the Pancreatic Cancer alliance in 20051.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1335017132 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “Dario Altieri” revision 1335017132 · retrieved 2026-10-20 date of foundation (×1) · confidence 0.95 revision URL